Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $5,313 | 2 | 85.7% |
| Food and Beverage | $730.53 | 17 | 11.8% |
| Travel and Lodging | $156.36 | 1 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Incyte Corporation | $5,313 | 2 | $0 (2023) |
| Janssen Biotech, Inc. | $180.05 | 3 | $0 (2024) |
| National Marrow Donor Program | $156.36 | 1 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $123.12 | 1 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $119.98 | 1 | $0 (2017) |
| Legend Biotech USA Inc. | $107.39 | 3 | $0 (2024) |
| Celgene Corporation | $87.81 | 3 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $61.09 | 3 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $33.24 | 2 | $0 (2017) |
| BeiGene USA, Inc. | $17.85 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $318.46 | 7 | Janssen Biotech, Inc. ($135.25) |
| 2023 | $458.01 | 2 | Incyte Corporation ($425.00) |
| 2022 | $5,270 | 8 | Incyte Corporation ($4,888) |
| 2017 | $153.22 | 3 | Merck Sharp & Dohme Corporation ($119.98) |
All Payment Transactions
20 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Legend Biotech USA Inc. | — | Food and Beverage | In-kind items and services | $43.42 | General |
| 09/18/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Food and Beverage | In-kind items and services | $135.25 | General |
| Category: Oncology | ||||||
| 08/22/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $25.18 | General |
| Category: Oncology | ||||||
| 07/30/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $29.94 | General |
| Category: Hematology | ||||||
| 05/30/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: Oncology | ||||||
| 04/18/2024 | Legend Biotech USA Inc. | — | Food and Beverage | In-kind items and services | $35.86 | General |
| 03/07/2024 | Legend Biotech USA Inc. | — | Food and Beverage | In-kind items and services | $28.11 | General |
| 06/13/2023 | Incyte Corporation | — | Consulting Fee | Cash or cash equivalent | $425.00 | General |
| 02/22/2023 | Celgene Corporation | ONUREG (Drug) | Food and Beverage | Cash or cash equivalent | $33.01 | General |
| Category: Oncology | ||||||
| 10/21/2022 | Incyte Corporation | — | Consulting Fee | Cash or cash equivalent | $4,887.50 | General |
| 09/28/2022 | SANOFI-AVENTIS U.S. LLC | REZUROCK (Drug) | Food and Beverage | In-kind items and services | $123.12 | General |
| Category: Oncology | ||||||
| 09/02/2022 | National Marrow Donor Program | — | Travel and Lodging | In-kind items and services | $156.36 | General |
| 06/13/2022 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Oncology | ||||||
| 05/18/2022 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: Oncology | ||||||
| 05/17/2022 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: ONCOLOGY | ||||||
| 04/27/2022 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: Oncology | ||||||
| 04/21/2022 | Celgene Corporation | ONUREG (Drug) | Food and Beverage | Cash or cash equivalent | $24.86 | General |
| Category: Oncology | ||||||
| 10/26/2017 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $119.98 | General |
| Category: ONCOLOGY | ||||||
| 03/02/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/19/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 74 | 301 | $73,651 | $33,075 |
| 2022 | 4 | 98 | 300 | $96,160 | $32,923 |
| 2021 | 1 | 19 | 27 | $8,100 | $3,575 |
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 36 | 227 | $49,816 | $23,504 | 47.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 25 | 61 | $18,335 | $7,610 | 41.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 13 | 13 | $5,500 | $1,961 | 35.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 34 | 188 | $37,600 | $16,966 | 45.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 32 | 77 | $23,100 | $10,002 | 43.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 20 | 22 | $9,460 | $3,843 | 40.6% |
| 38241 | Transplantation of patient-derived stem cells | Facility | 2022 | 12 | 13 | $26,000 | $2,113 | 8.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 19 | 27 | $8,100 | $3,575 | 44.1% |
About Dr. Alaa Ali, MD
Dr. Alaa Ali, MD is a Hematology & Oncology healthcare provider based in Tampa, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/27/2012. The National Provider Identifier (NPI) number assigned to this provider is 1841546876.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alaa Ali, MD has received a total of $6,199 in payments from pharmaceutical and medical device companies, with $318.46 received in 2024. These payments were reported across 20 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($5,313).
As a Medicare-enrolled provider, Ali has provided services to 191 Medicare beneficiaries, totaling 628 services with total Medicare billing of $69,574. Data is available for 3 years (2021–2023), covering 8 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Location Tampa, FL
- Active Since 07/27/2012
- Last Updated 11/21/2025
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1841546876
Products in Payments
- DARZALEX (Biological) $135.25
- REZUROCK (Drug) $123.12
- KEYTRUDA (Biological) $119.98
- ONUREG (Drug) $57.87
- SCEMBLIX (Drug) $45.88
- IMBRUVICA (Drug) $44.80
- XARELTO (Drug) $33.24
- REBLOZYL (Biological) $29.94
- BRUKINSA (Drug) $17.85
- PROMACTA (Drug) $15.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Tampa
Damian Laber, Md, MD
Hematology & Oncology — Payments: $1.4M
Eduardo Sotomayor, Md, MD
Hematology & Oncology — Payments: $447,992
Ariel Grajales-Cruz
Hematology & Oncology — Payments: $424,303
Dr. Kendra Sweet, M.d, M.D
Hematology & Oncology — Payments: $215,309
Khaldoun Almhanna, Md, Mph, MD, MPH
Hematology & Oncology — Payments: $173,538
Hayder Saeed, M.d, M.D
Hematology & Oncology — Payments: $140,365